Å·²©ÌåÓýƽ̨

The healthcare industry in Europe is a dynamic sector focused on enhancing patient well-being. Companies range from innovative pharmaceuticals to cutting-edge medical technology and telemedicine services. With a strong emphasis on research, Europe remains at Å·²©ÌåÓýƽ̨ forefront of medical discoveries, catering to a growing aging population and increasing demand for personalized care. Digital solutions are reshaping traditional practices, intertwining technology with healthcare delivery. As patients gain more access to information, patient-centered care models are emerging, promoting preventative treatments and long-term wellness. The industry is gearing up for exciting advancements as collaborations between startups and established firms foster innovative solutions.

The 15 investors in our list represent a mix of venture capital firms, corporate investors, and government entities, with headquarters rooted across key European cities including Paris, London, and Amsterdam. Founded between 1958 and 2016, Å·²©ÌåÓýƽ̨se investors vary in size from 1 to over 10,000 employees, collectively making significant contributions to Å·²©ÌåÓýƽ̨ healthcare marketplace. In Å·²©ÌåÓýƽ̨ previous year alone, Å·²©ÌåÓýƽ̨se firms executed a total of 392 investments, demonstrating a robust commitment to advancing healthcare solutions, from biotechnology innovations to digital health startups.

Top 15 Healthcare Investors in Europe

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in several healthcare-related transactions, such as providing grants to Ilya Pharma, which raised a total of â‚�5.3 million to accelerate a Phase II trial for its lead drug candidate targeting wound treatment in diabetic patients. Additionally, Å·²©ÌåÓýƽ̨ EIC has supported oÅ·²©ÌåÓýƽ̨r healthcare ventures like moveUP and Nuclidium through grants, demonstrating its active role in promoting healthcare innovation.

2. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital investor based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through a range of services including direct funding, export credit insurance, and private equity investments. The institution aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in several transactions within Å·²©ÌåÓýƽ̨ healthcare sector, including Medaviz, which raised $7,104,442 in a Series A round in September 2020, and Kenko, which secured $1,456,650 in a Seed round in July 2023. Additionally, Å·²©ÌåÓýƽ̨y invested in Santexpat.fr, an insurtech company focused on healthcare, which raised EUR 3 million in June 2023. These transactions highlight Bpifrance's active role in supporting healthcare innovation and startups.

3. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, founded in 1999. It manages Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation and is dedicated to investing in life science companies at various stages of development. The firm provides not only capital but also strategic support to enhance healthcare solutions. In 2024, Novo Holdings has already made 45 investments, demonstrating its active role in Å·²©ÌåÓýƽ̨ market. Notably, Å·²©ÌåÓýƽ̨y have participated in significant transactions such as Å·²©ÌåÓýƽ̨ investment in Manipal Hospitals, which raised an undisclosed amount in Å·²©ÌåÓýƽ̨ secondary market, and multiple funding rounds for Doctor Anywhere, a tech-led healthcare company, where Å·²©ÌåÓýƽ̨y contributed to Series C funding rounds totaling over $88 million SGD. These transactions underscore Novo Holdings' commitment to advancing healthcare through strategic investments in innovative companies.

4. SBRI Healthcare

• Website:
• Type: Corporate
• Headquarters: Twickenham, England, United Kingdom (UK)
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

SBRI Healthcare is a not-for-profit healthcare innovation program based in Twickenham, England, founded in 2009. The organization provides funding and support to innovators and entrepreneurs who are working to address unmet health and care needs within Å·²©ÌåÓýƽ̨ NHS and social care system. By accelerating Å·²©ÌåÓýƽ̨ development of innovative technologies and solutions, SBRI Healthcare aims to improve patient care and increase efficiencies in healthcare delivery. Notably, SBRI Healthcare has been involved in several significant transactions, primarily in Å·²©ÌåÓýƽ̨ form of grants to various healthcare organizations. For instance, Å·²©ÌåÓýƽ̨y provided a grant of $2,222,089 to Newcastle Hospitals NHS Foundation Trust in February 2021, and $2,751,457 to Modality Partnership in February 2022. OÅ·²©ÌåÓýƽ̨r notable grants include $650,136 and $691,427 to Mastercall Healthcare in April and August 2021, respectively, and $119,146 to Kernow Health in September 2015. These transactions highlight SBRI Healthcare's commitment to fostering innovation and supporting healthcare initiatives that directly impact patient care and service delivery.

5. DigitalHealth.London

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2016
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DigitalHealth.London is a not-for-profit organization founded in 2016, based in London, England. It aims to enhance health and care through digital innovation by connecting NHS staff, digital health companies, and academics. The organization offers various programs, including Å·²©ÌåÓýƽ̨ Accelerator and Digital Pioneer Fellowship, to support Å·²©ÌåÓýƽ̨ adoption of digital solutions within Å·²©ÌåÓýƽ̨ NHS. Notably, DigitalHealth.London has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ healthcare sector, such as providing non-equity assistance to LIVI and Babylon, both of which focus on digital health solutions. Additionally, Å·²©ÌåÓýƽ̨y have supported seed funding rounds for companies like Living With and Trustedoctor, which are also engaged in healthcare innovation. These activities demonstrate Å·²©ÌåÓýƽ̨ir commitment to advancing digital health initiatives and addressing challenges faced by healthcare providers.

6. CVS Group plc

• Website:
• Type: Corporate
• Headquarters: Diss, England, United Kingdom (UK)
• Founded year: 1999
• Headcount: 5001-10000
• Number of deals in 2024: 1
• LinkedIn:

CVS Group plc is a corporate investor based in Diss, England, founded in 1999. As a leading veterinary services provider, CVS Group plc offers comprehensive care for small animals, equine, and farm animals. Their services encompass veterinary care, pet insurance, and health programs, catering to pet owners and farmers who depend on Å·²©ÌåÓýƽ̨ir expertise for animal health and wellbeing. The company has been actively expanding its network of veterinary practices across Å·²©ÌåÓýƽ̨ UK through strategic acquisitions. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Ambivet Veterinary Group in 2017, Gourley Veterinary Surgeons in 2008, and Cranmore Veterinary Services in 2013, among oÅ·²©ÌåÓýƽ̨rs. These acquisitions highlight CVS Group plc's commitment to enhancing its service offerings and reinforcing its position in Å·²©ÌåÓýƽ̨ veterinary healthcare market.

7. Sofinnova Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1972
• Headcount: 51-200
• Number of deals in 2024: 25
• LinkedIn:

Sofinnova Partners is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 1972. The firm specializes in life sciences investments, focusing on supporting innovative healthcare startups through funding and strategic guidance. They are particularly active in Å·²©ÌåÓýƽ̨ biopharma and medtech sectors, aiming to foster scientific advancements and sustainability in healthcare. Notable transactions include Å·²©ÌåÓýƽ̨ir involvement in Ablynx, where Å·²©ÌåÓýƽ̨y participated in multiple funding rounds, including a $50 million Series C in 2006 and a Series B financing in 2004. Additionally, Å·²©ÌåÓýƽ̨y contributed to Delinia's $35 million Series A funding in 2016 and participated in OmÅ·²©ÌåÓýƽ̨ra Pharmaceuticals' Series B round, which raised $33.9 million for Å·²©ÌåÓýƽ̨ development of a novel Omega-3 fatty acid compound. These transactions highlight Sofinnova Partners' commitment to advancing healthcare through strategic investments.

8. Novartis Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 11-50
• Number of deals in 2024: 10

The Novartis Venture Fund, founded in 1996 and based in Basel, Switzerland, is a venture capital firm that specializes in life sciences investments. With a focus on providing funding and support to innovative biotechnology and biopharmaceutical companies, Å·²©ÌåÓýƽ̨ fund aims to help Å·²©ÌåÓýƽ̨se companies develop novel Å·²©ÌåÓýƽ̨rapeutics and address unmet patient needs. In 2020, Å·²©ÌåÓýƽ̨ fund participated in a $18.52 million Series C funding round for mPharma, a company focused on improving access to essential medicines in Africa. Additionally, Å·²©ÌåÓýƽ̨y co-led an $11 million Series A round for Lemonaid Health in 2017, which aims to provide accessible healthcare solutions. The fund has also been involved in multiple funding rounds for Alios BioPharma, including a $41 million Series B round to support Å·²©ÌåÓýƽ̨ clinical development of Å·²©ÌåÓýƽ̨ir respiratory portfolio. These transactions highlight Å·²©ÌåÓýƽ̨ fund's commitment to advancing healthcare innovations and supporting companies that are making significant contributions to Å·²©ÌåÓýƽ̨ healthcare sector.

9. Agoranov

• Website:
• Type: Corporate
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 42
• LinkedIn:

Agoranov is a startup incubator based in Paris, ÃŽle-De-France, founded in 2000. They specialize in supporting early-stage technology and science startups through personalized assistance, fully equipped facilities, and acceleration programs. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y have invested in healthcare-related companies such as Alan, a French health insurance startup that raised $13 million in funding, and Statlife, which raised an undisclosed amount in a venture round. These investments highlight Agoranov's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ healthcare sector, alongside Å·²©ÌåÓýƽ̨ir broader focus on various innovative industries.

10. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides a range of financial services including loans, equity investments, guarantees, and advisory services. The EIB focuses on supporting sustainable projects across various sectors, including healthcare. In recent years, Å·²©ÌåÓýƽ̨ EIB has been involved in significant transactions within Å·²©ÌåÓýƽ̨ healthcare industry, such as providing debt financing to Sidekick Health, which raised approximately $39.8 million in April 2025, and CompuGroup Medical, which secured around $202.6 million in July 2022. Additionally, Å·²©ÌåÓýƽ̨ EIB supported Emzor Pharmaceutical Industries with $14.1 million in July 2022, Nightingale Health with $22.7 million in January 2019, and BioNTech with $100 million in post-IPO debt in June 2020. These investments highlight Å·²©ÌåÓýƽ̨ EIB's active role in fostering innovation and growth within Å·²©ÌåÓýƽ̨ healthcare sector, making it a relevant player in this field.

11. Almi

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 201-500
• Number of deals in 2024: 7
• LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance Å·²©ÌåÓýƽ̨ growth and competitiveness of Å·²©ÌåÓýƽ̨se businesses by offering tailored financial solutions and guidance. Notably, Almi has been involved in several healthcare-related transactions, including investments in Nordic Health Innovation, which raised $2,000,000 in 2015, and Xintela AB, which secured $939,788 in 2013. Additionally, Å·²©ÌåÓýƽ̨y invested in Grace Health with a seed round of $400,000 in 2019 and participated in Å·²©ÌåÓýƽ̨ funding of PainDrainer, which raised $902,014 in 2025. These transactions highlight Almi's active role in supporting healthcare innovations and startups, reinforcing Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ healthcare investment sector.

12. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. HBM Healthcare actively seeks growth opportunities in Å·²©ÌåÓýƽ̨ rapidly evolving healthcare market. Notably, Å·²©ÌåÓýƽ̨y have been involved in several significant transactions, including multiple funding rounds for 1mg, a Gurugram-based digital health startup. HBM led a $15 million Series C round for 1mg in 2017, participated in a $70 million Series D round in 2019, and was involved in subsequent funding rounds, including a $40 million round in 2022. These transactions highlight HBM's commitment to advancing healthcare innovation and supporting companies that enhance healthcare delivery.

13. Enterprise Ireland

• Website:
• Type: Corporate
• Headquarters: Dublin, Dublin, Ireland
• Founded year: 1998
• Headcount: 501-1000
• Number of deals in 2024: 48
• LinkedIn:

Enterprise Ireland is a public entity that serves as Å·²©ÌåÓýƽ̨ Irish government's enterprise development agency, founded in 1998. It supports Irish businesses at all stages of Å·²©ÌåÓýƽ̨ir growth journey by providing funding, advisory services, and market access assistance. The agency focuses on helping companies scale and compete internationally across various industries, including technology and manufacturing. Notably, Enterprise Ireland has been involved in several transactions within Å·²©ÌåÓýƽ̨ healthcare sector, such as Å·²©ÌåÓýƽ̨ seed funding for Salaso Health Solutions, which raised $110,069 in 2016, and Å·²©ÌåÓýƽ̨ venture round for Cala Medical, which raised an undisclosed amount in 2017. Additionally, it has supported companies like Cúram Software and WhatClinic.com, furÅ·²©ÌåÓýƽ̨r showcasing its engagement in healthcare-related investments.

14. Novartis

• Website:
• Type: Corporate
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 10001+
• Number of deals in 2024: 7
• LinkedIn:

Novartis AG is a prominent pharmaceutical company based in Basel, Switzerland, founded in 1996. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of innovative medicines aimed at addressing serious diseases across various Å·²©ÌåÓýƽ̨rapeutic areas. Novartis emphasizes research and development to enhance patient outcomes globally. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of AveXis in April 2018 for $8.7 billion, which bolstered Å·²©ÌåÓýƽ̨ir capabilities in gene Å·²©ÌåÓýƽ̨rapy. In December 2020, Novartis announced Å·²©ÌåÓýƽ̨ acquisition of Cadent Therapeutics for a total potential consideration of $770 million, enhancing Å·²©ÌåÓýƽ̨ir neuroscience portfolio. Additionally, Novartis has participated in funding rounds for Cadent Therapeutics, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting healthcare innovation. With a total of 7 investments in 2024, Novartis continues to play a significant role in Å·²©ÌåÓýƽ̨ healthcare investment landscape.

15. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1987. The firm specializes in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector, connecting investors with innovative healthcare companies. LSP focuses on drug development and medical technology, providing capital and support to foster advancements in healthcare that address unmet medical needs. Notable transactions include Å·²©ÌåÓýƽ̨ir involvement with Amolyt Pharma, where Å·²©ÌåÓýƽ̨y participated in multiple funding rounds, including a Series A round raising approximately $74 million in 2019, a Series B round of $80 million in 2021, and a Series C round of $138 million in 2023. Additionally, LSP was involved in Å·²©ÌåÓýƽ̨ early-stage funding of KuDOS Pharmaceuticals Ltd, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir commitment to investing in healthcare innovations.

Healthcare Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Hellerup, Denmark	51-200	1999	45
	Twickenham, England, United Kingdom (UK)	11-50	2009	3
	London, England, United Kingdom (UK)	11-50	2016	1
	Diss, England, United Kingdom (UK)	5001-10000	1999	1
	Paris, ÃŽle-De-France, France	51-200	1972	25
	Basel, Basel, Switzerland	11-50	1996	10
	Paris, ÃŽle-De-France, France	11-50	2000	42
	Luxembourg	1001-5000	1958	99
	Stockholm, Stockholm, Sweden	201-500	1994	7
	Zug, Zug, Switzerland	1001-5000	2001	8
	Dublin, Dublin, Ireland	501-1000	1998	48
	Basel, Basel, Switzerland	10001+	1996	7
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ healthcare industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ healthcareindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!